Venkata Rao Muppavarapu

Deputy General Manager @Riconpharma India Pvt Ltd

Hyderabad, TG, IN
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2024 — Present

Deputy General Manager @Riconpharma India Pvt Ltd

View department →

IN

Completed US FDA audit for in vitro bioequivalence studies of a complex extended-release capsule ANDA Achieved second-cycle FDA approval for a P-4 NCE-1 product through persuasive technical responses Secured FDA approval for extended-release capsule ANDA within a 13-month review cycle Led analytical method transfer to China CMO and filed successful ANDA Completed method transfers for three products to alternate manufacturing sites with first-cycle FDA approvals

EDUCATION

N/A

Sikkim Manipal University - Distance Education

Master of Business Administration - MBA , Operations Management and Supervision

N/A

Andhra University

Master's degree, Chemistry

2002 — 2004

Andhra University

Master's degree, Organic Chemistry (Chemistry and Analysis of Foods, Drugs and Water)

N/A

Vignan's Foundation for Science, Technology & Research

Doctor of Philosophy - PhD, Chemistry

N/A

Davidson College

Edx Certificate Programme (Collaboration with Novartis Institute for Biomedical Research), Medicinal and Pharmaceutical Chemistry

N/A

Indian Institute of Management, Kozhikode

Certificate Programme, Project Management

ABOUT VENKATA RAO MUPPAVARAPU

Quality means doing it right when no one is looking.\" – Henry FordMy 21-year journey in the pharmaceutical industry has been rooted in one pursuit: transforming analytical precision into regulatory success.From the labs of Orchid and Dr. Reddy’s to my current leadership at RiconPharma, I have built a career at the intersection of scientific rigor and regulatory execution. I specialize in designing, validating, and transferring analytical methods that meet the highest global standards—while anticipating and addressing FDA scrutiny with confidence.Currently, I serve as Deputy General Manager at RiconPharma, where I have been instrumental in securing multiple FDA approvals for complex ANDAs, including extended-release, osmotic, and bi-component dosage forms. My success rate includes first-cycle approvals and review completions in as little as 13 months—an outcome of detailed method development, robust documentation, and strategic query responses.My strength lies in integrating project management with lab operations, supported by certifications from IIM Kozhikode and global programs like the Davidson College–Novartis collaboration. Whether managing site transfers to CMOs in China or mentoring junior analysts, I believe in fostering accuracy, compliance, and growth.Let\'s connect if you\'re focused on accelerating regulatory timelines, improving lab efficiencies, or building high-performing analytical teams.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.